Latest News

  • Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress Read More
  • Alkermes to Present at the Cantor Fitzgerald Global Healthcare Conference Read More
  • Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D. Read More

Investors

Working at Alkermes